134419-55-9 Usage
Description
(((4-bromotetrahydro-2H-pyran-3-yl)amino)methyl)-2-nitro-1H-imidazole-1-ethanol, also known as Nitazoxanide, is a broad-spectrum antiparasitic and antiviral medication. It is characterized by its ability to treat a wide range of parasitic and viral infections, including cryptosporidiosis, giardiasis, and viral gastroenteritis. Nitazoxanide functions by disrupting the energy metabolism of parasites and viruses, leading to their death. It is available in oral suspension and tablet forms and has been proven effective for treating infections in both adults and children. However, caution should be exercised in patients with liver disease or those taking other medications that may interact with it.
Uses
Used in Pharmaceutical Industry:
(((4-bromotetrahydro-2H-pyran-3-yl)amino)methyl)-2-nitro-1H-imidazole-1-ethanol is used as an antiparasitic and antiviral agent for treating various infections such as cryptosporidiosis, giardiasis, and viral gastroenteritis. Its broad-spectrum activity makes it a valuable asset in the treatment of these conditions, providing a versatile solution for healthcare providers and patients alike.
Used in Medical Treatments:
(((4-bromotetrahydro-2H-pyran-3-yl)amino)methyl)-2-nitro-1H-imidazole-1-ethanol is used as a therapeutic agent for combating parasitic and viral infections in both adults and children. Its effectiveness in treating a range of infections makes it a crucial component in medical treatments, offering relief and improved health outcomes for those affected by these conditions.
Used in Research and Development:
(((4-bromotetrahydro-2H-pyran-3-yl)amino)methyl)-2-nitro-1H-imidazole-1-ethanol is utilized in research and development for the study of parasitic and viral infections, as well as the development of new treatments and therapies. Its unique mechanism of action and broad-spectrum capabilities make it an important subject for scientific investigation and potential innovation in the field of infectious diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 134419-55-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,4,4,1 and 9 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 134419-55:
(8*1)+(7*3)+(6*4)+(5*4)+(4*1)+(3*9)+(2*5)+(1*5)=119
119 % 10 = 9
So 134419-55-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H17BrN4O4/c12-9-1-4-20-7-10(9)14-5-8(17)6-15-3-2-13-11(15)16(18)19/h2-3,8-10,14,17H,1,4-7H2
134419-55-9Relevant articles and documents
2-nitroimidazole derivatives useful as radiosensitizers for hypoxic tumor cells
-
, (2008/06/13)
Certain α-[(2-nitro-1H-imidazol-1-yl)methyl]-aziridinylethanols and the corresponding aziridine-ring opened analogs are useful as radiation sensitizers for X-irradiation therapy of tumors.
